Biotech News, What Milestones and Catalysts Could Drive BioLineRx Shares in 2019

ACCESSWIRE

Wed, May 1, 2019, 8:10 AM

In this article:

NEW YORK, NY / ACCESSWIRE / May 1, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on BioLineRx Ltd. (BLRX) is a clinical stage biopharmaceutical development company, focused on oncology and immunology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.

Recently, the company reported its financial results for the year ended December 31, 2018 and provided a corporate update.

Review the milestones achieved in 2018 and potential catalyst for 2019 READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/biolinerx-2/

Get a broader look at the BLRX pipeline and recent stem-cell developments READ MORE

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com

SOURCE: Traders News Source

View source version on accesswire.com:
https://www.accesswire.com/543518/Biotech-News-What-Milestones-and-Catalysts-Could-Drive-BioLineRx-Shares-in-2019

‘Americans just work harder’ than Europeans, says CEO of Norway’s $1.6 trillion oil fund, because they have a higher ‘general level of ambition’
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
Fortune•20h ago
Warren Buffett Says 'When It Rains Gold, Put Out The Bucket' And This High Yield Investment Is Making It Rain
In his 2016 letter to Berkshire Hathaway shareholders, legendary investor Warren Buffett wrote, “Every decade or so, dark clouds will fill the economic skies, and they will briefly rain gold. When downpours of that sort occur, it’s imperative that we ...
Benzinga•13h ago
Microsoft beats Q3 top and bottom lines on cloud strength
Microsoft reported better than anticipated Q3 earnings on Thursday, powered by growth in its cloud products.
Yahoo Finance•8h ago
Billionaire 'bond king' Bill Gross tells investors to avoid tech and stick to value stocks
Gross said in a post on X to avoid tech, but if you have to invest in the sector, one name stands out.
Business Insider•3h ago
The Vanguard 500 Index Fund Is Great, But Another Vanguard ETF Has Outperformed It the Past Decade
This growth ETF has nicely outperformed the S&P 500 since its inception.
Motley Fool•21h ago
Hertz loses another $200 million from its EVs
Car-rental operator Hertz reported it lost another $200 million due to its EV gamble.
Yahoo Finance•13h ago
Javier Milei Fuels Wild Rally That Makes Peso No. 1 in World
(Bloomberg) -- Four months into office, Argentine President Javier Milei has pulled off a critical feat in a country long ravaged by runaway inflation: He stabilized the currency.Most Read from BloombergUS Economy Slows and Inflation Jumps, Damping Soft-Landing HopesJavier Milei Fuels Wild Rally That Makes Peso No. 1 in WorldMalaysia in Talks With Tycoons on Casino to Revive $100 Billion Forest CityPlunging Home Prices, Fleeing Companies: Austin’s Glow Is FadingBig Tech Surges in Late Hours on B
Bloomberg•14h ago
The US economy may be barrelling towards stagflation, an outcome worse than recession
As US growth shows signs of sputtering and inflation keeps rising, a re-run of the tumultuous 1970s is looking more likely.
Business Insider•4h ago
Mark Zuckerberg got $24.4 million in ‘other compensation’ in 2023—but Meta also treated staff well, with the median employee making $379,000
On paper, Mark Zuckerberg is Meta’s lowest-paid employee, with a $1 dollar salary and no bonus.
Fortune•2d ago
Intel reports better than expected Q1 earnings but falls short on revenue outlook. Stock slides more than 5%.
Intel reported its Q1 earnings on Thursday, beating analysts' estimates. But a disappointing outlook sent shares sliding.
Yahoo Finance•11h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Biotech News, What Milestones and Catalysts Could Drive BioLineRx Shares in 2019

Recommended Stories

‘Americans just work harder’ than Europeans, says CEO of Norway’s $1.6 trillion oil fund, because they have a higher ‘general level of ambition’

Warren Buffett Says 'When It Rains Gold, Put Out The Bucket' And This High Yield Investment Is Making It Rain

Microsoft beats Q3 top and bottom lines on cloud strength

Billionaire 'bond king' Bill Gross tells investors to avoid tech and stick to value stocks

The Vanguard 500 Index Fund Is Great, But Another Vanguard ETF Has Outperformed It the Past Decade

Hertz loses another $200 million from its EVs

Javier Milei Fuels Wild Rally That Makes Peso No. 1 in World

The US economy may be barrelling towards stagflation, an outcome worse than recession

Mark Zuckerberg got $24.4 million in ‘other compensation’ in 2023—but Meta also treated staff well, with the median employee making $379,000

Intel reports better than expected Q1 earnings but falls short on revenue outlook. Stock slides more than 5%.